showed a trendp = 0.140
Outcome analysis in the whole cohort (Table 2 ) showed a trend towards a reduction of stage 2–3 AKI in the HOPE group (87 [32.3%] versus 4 [16%]; p = 0.140).
Outcome analysis in the whole cohort (Table 2 ) showed a trend towards a reduction of stage 2–3 AKI in the HOPE group (87 [32.3%] versus 4 [16%]; p = 0.140).